Vivopharm Holding ApS: Financial statements 2025
CVR: 41452935
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Vivopharm Holding ApS (CVR 41452935) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -7,131 and a net result of DKK -8,935 compared with DKK -8,097 the year before. Equity in the 2025 report amounted to DKK -44,186.
- Gross Profit
- DKK -7,131
- Profit/Loss
- DKK -8,935
- Equity
- DKK -44,186
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -7K | -9K | -44K | 0 |
| 2024 | - | -7K | -8K | -35K | 1 |
| 2023 | - | -7K | -7K | -27K | 1 |
| 2022 | - | -7K | -107K | -20K | 1 |
| 2021 | - | -6K | -6K | 88K | 1 |
Official annual report
How creditworthy is Vivopharm Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Vivopharm Holding ApS has published its annual report for 2024. Gross profit came to DKK -7,188, and the net result was DKK -8,097.
About Vivopharm Holding ApS
Vivopharm Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gert Mads Bolwig. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,131 and a net result of DKK -8,935 compared with DKK -8,097 the year before. Equity in the 2025 report amounted to DKK -44,186.